Advanced search
Publication Cover
Journal of Inflammation Research Volume 14, 2021 - Issue
Submit an article Journal homepage
68
Views
0
CrossRef citations to date
0
Altmetric
Original Research

A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis

Nobuyasu IshiiFirst Department of Internal Medicine, Kansai Medical University, Moriguchi-City, Osaka, 570-8507, Japan
,
Toshiki ShimizuFirst Department of Internal Medicine, Kansai Medical University, Moriguchi-City, Osaka, 570-8507, JapanCorrespondence[email protected]
,
Yoshihisa IshiuraFirst Department of Internal Medicine, Kansai Medical University, Moriguchi-City, Osaka, 570-8507, Japan
,
Hideki AmuroFirst Department of Internal Medicine, Kansai Medical University, Moriguchi-City, Osaka, 570-8507, Japan
,
Tohru NishizawaFirst Department of Internal Medicine, Kansai Medical University, Moriguchi-City, Osaka, 570-8507, Japan
,
Takeshi TamakiFirst Department of Internal Medicine, Kansai Medical University, Moriguchi-City, Osaka, 570-8507, JapanORCID Iconhttps://orcid.org/0000-0002-9402-119X
ORCID Icon &
Shosaku NomuraFirst Department of Internal Medicine, Kansai Medical University, Moriguchi-City, Osaka, 570-8507, Japan
 show all
Pages 3721-3728 | Published online: 05 Aug 2021

References

  • Pope JE, Choy EH. C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. Semin Arthritis Rheum. 2021;51(1):219–229. doi:10.1016/j.semarthrit.2020.11.005
  • Nishimoto N, Kishimoto T, Yoshizaki K. Anti-interleukin 6 receptor antibody treatment in rheumatic disease. Ann Rheum Dis. 2000;59(Suppl1):i21–i27. doi:10.1136/ard.59.suppl_1.i21
  • Emery P, Keystone E, Tony HP, et al. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis. 2008;67(11):1516–1523. doi:10.1136/ard.2008.092932
  • Smolen JS, Aletaha D. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants. Arthritis Rheum. 2011;63(1):43–52. doi:10.1002/art.27740
  • Burmester GR, Rubbert-Roth A, Cantagrel A, et al. A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study). Ann Rheum Dis. 2014;73(1):69–74.
  • Choy EH, Bernasconi C, Aassi M, Molina JF, Epis OM. Treatment of rheumatoid arthritis with anti-tumor necrosis factor or tocilizumab therapy as first biologic agent in a global comparative observational study. Arthritis Care Res. 2017;69(10):1484–1494. doi:10.1002/acr.23303
  • Arnett FC, Edworthy SM, Bloch DA, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–324. doi:10.1002/art.1780310302
  • Kay J, Upchurch KS. ACR/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology. 2012;51(suppl_6):vi5–vi9. doi:10.1093/rheumatology/kes279
  • Pers YM, Fortunet C, Constant E, et al. Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice. Rheumatology. 2014;53(1):76–84. doi:10.1093/rheumatology/ket301
  • Tillett WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med. 1930;52(4):561–571. doi:10.1084/jem.52.4.561
  • Mold C, Nakayama S, Holzer TJ, Gewurz H, Du Clos TW. C-reactive protein is protective against Streptococcus pneumoniae infection in mice. J Exp Med. 1981;154(5):1703–1708. doi:10.1084/jem.154.5.1703
  • Castell JV, Gómez-Lechón MJ, David M, et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 1989;242(2):237–239. doi:10.1016/0014-5793(89)80476-4
  • Aletaha D, Funovits J, Keystone EC, Smolen JS. Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients. Arthritis Rheum. 2007;56(10):3226–3235. doi:10.1002/art.22943
  • Alonzi T, Fattori E, Lazzaro D, et al. Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med. 1998;187(4):461–468. doi:10.1084/jem.187.4.461
  • Fujimoto M, Serada S, Mihara M, et al. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses. Arthritis Rheum. 2008;58(12):3710–3719. doi:10.1002/art.24126
  • Ebina K, Hashimoto M, Yamamoto W, et al. Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study. Arthritis Res Ther. 2019;21(1):91. doi:10.1186/s13075-019-1880-4
  • Kawabe A, Nakano K, Kubo S, Asakawa T, Tanaka Y. Differential long-term retention of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis by age group from the FIRST registry. Arthritis Res Ther. 2020;22(1):136. doi:10.1186/s13075-020-02233-9
  • Alpay-Kanitez N, Pehlivan O, Omma A, et al. Favorable retention rates and safety of conventional anti-rheumatic drugs in older patients with rheumatoid arthritis. Medicine. 2020;99(16):e19696. doi:10.1097/MD.0000000000019696
  • Nikolaisen C, Figenschau Y, Nossent JC. Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality. J Rheumatol. 2008;35(3):380–386.
  • Zhang D, Zhou X, Yan S, et al. Correlation between cytokines and coagulation-related parameters in patients with coronavirus disease 2019 admitted to ICU. Clin Chim Acta. 2020;510:47–53. doi:10.1016/j.cca.2020.07.002
  • Buch MH. Defining refractory rheumatoid arthritis. Ann Rheum Dis. 2018;77(7):966–969. doi:10.1136/annrheumdis-2017-212862

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.